Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

Clinical trial NCT07270991 · RECRUITING

Trial details

NCT number: NCT07270991
Sponsor: Federation Francophone de Cancerologie Digestive
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Oesogastric Adenocarcinoma

Start date: 2025-12-15
Primary completion: 2030-11-30
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.